Skip to main content
Premium Trial:

Request an Annual Quote

Nexia to Acquire DNA Sequencing Reagent Maker Axis Labs

NEW YORK, Aug. 31 (GenomeWeb News) - Nexia Holdings will acquire Axis Labs, which is developing a reagent for DNA sequencing, for 165,000 shares of its class C preferred stock, Nexia said yesterday.


The amount of the deal was not immediately known and officials from both companies were not available for comment at deadline.


Axis Labs has been developing Molecular Imprinted Polymers for various commercial applications, including a process to remove BigDye terminators in automated DNA sequencing.


"We have discussed tentative agreements for brand alliances and manufacturing through well-known distribution channels in the DNA products industry" for the product, called Sequester, Kent Johnson, Axis' director of marketing and sales, said in a statement.

The Scan

Mosquitos Genetically Modified to Prevent Malaria Spread

A gene drive approach could be used to render mosquitos unable to spread malaria, researchers report in Science Advances.

Gut Microbiomes Allow Bears to Grow to Similar Sizes Despite Differing Diets

Researchers in Scientific Reports find that the makeup of brown bears' gut microbiomes allows them to reach similar sizes even when feasting on different foods.

Finding Safe Harbor in the Human Genome

In Genome Biology, researchers present a new approach to identify genomic safe harbors where transgenes can be expressed without affecting host cell function.

New Data Point to Nuanced Relationship Between Major Depression, Bipolar Disorder

Lund University researchers in JAMA Psychiatry uncover overlapping genetic liabilities for major depression and bipolar disorder.